Navigation Links
Medivation Announces Presentation of Full Top-Line Data From,Dimebon Six-Month Trial at Major International Alzheimer's Disease,Conference

acebo consistently across all five endpoints studied, including both of the endpoints accepted by the FDA to register drugs for mild to moderate Alzheimer's disease. And second, Dimebon was well tolerated in this study, with less than three percent incidence of the gastrointestinal side effects that sometimes limit utilization of approved cholinesterase inhibitor drugs. Based on these data, I look forward to participating in the planned Phase 3 trials of this promising drug candidate."

The study of 183 patients was conducted at multiple sites in Russia. Patients received oral Dimebon, 20 mg three times a day (60 mg/day), or placebo. The primary efficacy endpoint was the ADAS-cog and the secondary efficacy endpoints were the CIBIC-plus, the MMSE, the ADCS-ADL and the NPI. Medivation is presently completing a 12-month extension of this trial and expects to report top-line data in the second quarter of 2007. Medivation also expects to enter global Phase 3 studies of Dimebon in Alzheimer's disease in 2008 and, assuming positive data, to submit marketing applications in the U.S. and Europe in 2010 for this indication.

About Dimebon

Dimebon, the Company's lead product candidate, is an orally-available small molecule that has been shown to inhibit brain cell death in preclinical models relevant to Alzheimer's disease and Huntington's disease, making it a potential treatment for these and other neurodegenerative diseases. Based on the clinical and preclinical data generated to date, Medivation believes that Dimebon operates by a novel mechanism of action and may exert a neuroprotective effect in multiple areas of the central nervous system. Dimebon appears to block a new target that involves mitochondrial pores, which are believed to play a role in the cell death that is associated with neurodegenerative diseases and the aging process. Medivation is currently evaluating Dimebon in clinical trials in both Alzheimer's and Huntington's diseases.

Abo
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Medivations Dimebon Maintains Statistically Significant Benefit on All Five Efficacy Endpoints in Alzheimers Disease Trial After One Year of Therapy
2. Medivation to Host Conference Call to Discuss Top-Line 12-Month Results From Dimebon Alzheimers Disease Study
3. Medivation Announces Presentation of New Subset Analyses From Dimebon Phase 2 Alzheimers Disease Trial at American Academy of Neurology Annual Meeting
4. Medivation Announces First U.S. Presentation of Data From Dimebon Phase 2 Alzheimers Disease Trial at American Academy of Neurology Annual Meeting
5. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
6. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
9. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
10. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
Post Your Comments:
(Date:8/29/2014)... DUBLIN, Ohio , Aug. 29, 2014  In ... addresses how to leverage a hospital pharmacy as a ... president and national practice leader for Cardinal Health,s Innovation ... quality pharmacy care can benefit both hospitals and patients. ... orders is only one part of their job in ...
(Date:8/29/2014)... DUBLIN , August 29, 2014 ... management and collaboration software has announced a major new ... services, founded by renowned pathology expert, Dr. Marius ... advance of the 26th European Congress of Pathology which ... in the ExCeL Arena, London ...
(Date:8/28/2014)... Aug. 28, 2014 Reportlinker.com announces that ... its catalogue: North America Aesthetic Lasers ... http://www.reportlinker.com/p02343466/North-America-Aesthetic-Lasers-and-Energy-Devices-Market-Outlook-to-2020.html North ... to 2020 Summary GlobalData,s new report, ... Outlook to 2020", provides key market data on ...
Breaking Medicine Technology:Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 2Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 4Pixcelldata Announces New Deal with Dutch Tele-Pathology Specialists eX-Path Ahead of ECP 2014 2North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 2North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 3North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 4North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 5North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 6North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 7North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 8North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 9North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 10North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 11North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 12North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 13North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 14North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 15North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 16
... May 20, 2011 Advanced Life Sciences ... it has cancelled its Annual Meeting of Shareholders, which ... 24, 2011.   (Logo:   http://photos.prnewswire.com/prnh/20080218/ALSLOGO ) ... Advanced Life Sciences is a biopharmaceutical company engaged ...
... The U.S. Food and Drug Administration today approved Sutent ... located in the pancreas that cannot be removed by ... the body (metastatic). (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ... are slow-growing and rare. It is estimated that there ...
Cached Medicine Technology:FDA Approves Sutent for Rare Type of Pancreatic Cancer 2
(Date:8/30/2014)... Recently, Top 10 Best SEO ... and announced that BlueHost and JustHost ( http://www.justhost.com/track/seohosts ... want to buy high quality web hosting. ... best web host companies who outperform their competitors ... top-level support.” A spokesman for Top 10 Best ...
(Date:8/30/2014)... 31, 2014 Recently, iFitDress.com, one of ... new designs of classy bridesmaid dresses . For ... (from 22 percent off to 62 percent off) for ... beautiful items. , True enough, iFitDress.com is an ... occasion gowns. The company persists in making trendy products ...
(Date:8/30/2014)... Fast hosting is a great choice ... compared many professional web hosting suppliers and announces ... are the suppliers of fastest web hosting in ... good fast hosting supplier. Actually, these companies have ... speed and customer support. People can get the ...
(Date:8/30/2014)... 2014 Recently, Skmen.com, a well-known clothing ... casual dresses . Before the middle of September, all ... discounted price, from 15 to 30 percent off. ... long casual outfits are carefully made and come with ... for the wearers. Skmen.com is popular for its fashionable, ...
(Date:8/30/2014)... TX (PRWEB) August 30, 2014 Information ... Pros company to introduce better prices to consumers in ... plans can be found when using the open system ... national lookup system available to use this year can ... insurance based on general location and not from medical ...
Breaking Medicine News(10 mins):Health News:Great Web Hosting Suppliers Recently Recommended by Top10BestSEOHosting.com 2Health News:Classy Bridesmaid Dresses Announced By Loved Online Supplier iFitDress.com 2Health News:Fastest Web Hosting Suppliers In 2014 Announced By Top10BestSEOHosting.com 2Health News:Huge Deals On 2014 Long Casual Dresses Unveiled By Skmen.com 2Health News:Term Life Insurance Rates Now Found Nationally by New Insurer Finder Tool 2
... conducting an internal survey to better help diplomats cope with ... , a Department official said in testimony to Congress on ... State Department's Office of Medical Services, told a House of ... the Department's intranet system on June 1, and will collect ...
... female relatives may be unaware they carry a genetic risk ... casts doubt on current genetic testing guidelines . ... gene mutation in women with fewer than two female relatives ... sides of the family, according to researchers in California. ...
... Climate models represent variability in ocean heat content ... previously believed , a study by an Indian ... previously at Livermore's Program for Climate Model Diagnosis ... used 13 numerical climate models to find the ...
... upper echelons of the human brain's chain-of-command, has found ... in charge of the brain . ,Neuroscientists ... found that these two commanders are networks of brain ... work toward a common intention i.e. control of voluntary, ...
... die each year in the Asia-Pacific region due to ... regional conference on Wednesday . ,There ... Southeastern Asia whose deaths are attributed to something as ... UN children's agency (UNICEF) regional advisor Stephen Atwood. ...
... guesthouse inside the campus to save a dozen chinar trees ... Chancellor Abdul Wahid Qureshi halted the construction inside the chinar ... had launched an aggressive campaign to draw public attention to ... for the construction. ,"I have passed orders so ...
Cached Medicine News:Health News:US Concerned About Mental Health of Diplomats in Iraq, Afghanistan 2Health News:IIT Delhi Scientist Finds Climate Models Consistent With Ocean Warming Observations 2Health News:Two, Not One Networks Rule Brain's Voluntary Chain-of-command 2Health News:Two, Not One Networks Rule Brain's Voluntary Chain-of-command 3Health News:Decline in Breastfeeding Linked to Child Deaths in Asia: UNICEF 2
... CytoFuge 2 is the perfect solution for ... controls and new snap-seal Filter Concentrators make ... processed quickly, silently and conveniently on any ... are consistent: easy to scan monolayer cell ...
Unique "finger-stick" collection system utilizes a capillary tube for easy blood drawing; no "scooping" necessary. After draining into a microtube, blood is centrifuged and serum or plasma is easily ...
... Productivity, improved safety and lower cost per test ... to sample prep bottlenecks in the busy clinical ... compact and quiet centrifuge spins standard 5 mL ... it produces quality serum or plasma equal to ...
Used to provide drainage of urine from the bladder. All-silicone construction provides maximum softness and biocompatibility for enhanced patient comfort. Supplied sterile in peel-open packages. Inte...
Medicine Products: